Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 5,934 shares at $31.84 ($189K) on 2024-08-21, disclosed to the SEC on 2024-08-23.
Seasonal sale ($189k) by Chief Development Officer — this insider has traded IMVT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.84 | 2,907 | $93K | 49.0% |
| 2 | $31.84 | 2,907 | $93K | 49.0% |
| 3 | $32.32 | 120 | $4K | 2.1% |
| Total | $31.85 avg | 5,934 | $189K | 100% |
| Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |
| IMVT | SELL | 2024-04-10 | $33K | — | Filing → |